Description of Project: : QIAGEN Beverly, Inc. was contracted to expand manufacturing capacity of enzymatic reagents and reagent kits used in COVID-19 molecular diagnostic tests. Unique Impact: Molecular laboratory-based tests are essential for COVID-19 testing and diagnostics. The reagents QIAGEN produces are used to detect SARS-CoV-2 in
Capacity Reagent Bottle Science QIAGEN
Inquiry
Send on email.all fields width on * are required. Please enter your question and contact information.we will get back to you as soon as possible!